HealthDay – Dr. Joshua Zeichner: "FDA Approves 1st Topical Gel to Ease Redness of Rosacea"
The U.S. Food and Drug Administration on Monday approved Mirvaso (brimonidine) for the treatment of the redness–clinically known as erythema–that is a hallmark of rosacea.
"Up until this point, we have only had drugs to treat the bumps and pus pimples of rosacea," said Joshua Zeichner, MD, Director of Cosmetic and Clinical Research in the Department of Dermatology at The Mount Sinai Medical Center. "The approval of Mirvaso is very exciting because for the first time, we have a medication to treat facial redness of rosacea, which previously could only be addressed with lasers. Facial redness is a significant issue for rosacea patients, so this drug will fill a large, unmet need." Learn more